Liquidity and Capital Resources (Details)		3 Months Ended								6 Months Ended	12 Months Ended						18 Months Ended
	Jun. 10, 2019 USD ($)	Dec. 31, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Mar. 31, 2017 USD ($)	Dec. 30, 2020 USD ($)	Jun. 10, 2021	Jun. 10, 2020	May 31, 2020 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Jun. 20, 2022 USD ($)	Dec. 31, 2020	Dec. 31, 2015 USD ($)
Loss Contingencies [Line Items]
Cash and cash equivalents		$ 45,118,000				$ 27,476,000								$ 45,118,000	$ 27,476,000	$ 30,321,000			$ 26,301,000
Total current assets		74,049,000				48,747,000								74,049,000	48,747,000	59,474,000
Total current liabilities		71,547,000				45,810,000								71,547,000	45,810,000	60,792,000
Net working capital		2,500,000												2,500,000
Net cash flows from operating activities														35,796,000	62,939,000	23,849,000
Operating loss														(3,924,000)	46,223,000	884,000
Net income (loss)		(36,224,000)	$ (178,000)	$ 1,804,000	$ 4,619,000	4,276,000	$ 44,051,000	$ 10,402,000	$ 5,998,000					(29,979,000)	64,727,000	$ 390,000
Kruchoski et. al. v. Mimedx Group, Inc.
Loss Contingencies [Line Items]
Anticipated cash requirements for settlements		6,900,000				$ 5,600,000								6,900,000	$ 5,600,000
Litigation Involving Former Employees
Loss Contingencies [Line Items]
Anticipated cash requirements for settlements		$ 4,800,000												$ 4,800,000
Term Loan Agreement | Term Loan | Subsequent Event
Loss Contingencies [Line Items]
Face value of debt	$ 75,000,000.0
Quarterly installments	$ 900,000
Total leverage ratio	3.0
Term Loan Agreement | Term Loan | Forecast
Loss Contingencies [Line Items]
Total leverage ratio																		2.50
Minimum liquidity										$ 30,000,000.0			$ 40,000,000.0				$ 20,000,000.0
Prepayment penalty as percent of prepaid principal											2.00%	3.00%